Athersys-Partnered Japanese Ischemic Stroke Study Disappoints, Shares Plunge
Athersys Inc's (NASDAQ: ATHX) partner, Healios K.K. has reported topline results for its Japan ischemic stroke study, TREASURE.
Athersys: Q1 Earnings Insights
Athersys (NASDAQ:ATHX) reported its Q1 earnings results on Friday, May 6, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
The Daily Biotech Pulse: Limited Use Of JNJ’s COVID-19 Shot, Myovant-Pfizer’s Relugolix Application Delayed, Gain Therapeutics’ Parkinson’s Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For May 6, 2022
Companies Reporting Before The Bell
• Brookfield Renewable (NYSE:BEP) is expected to report quarterly loss at $0.02 per share on revenue of $1.27 billion.
Earnings Outlook For Athersys
Athersys (NASDAQ:ATHX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need to know before the announcement.
Analysts estimate that Athersys will report an earnings per share (EPS) of $-0.10.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers
Zosano Pharma (NASDAQ:ZSAN) shares rose 3127.9% to $3.88 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.0 million.
